International Recognition for Sahlgrenska University Hospital
Sahlgrenska University Hospital continues to strengthen its international reputation through sustained improvements in patient care, clinical research and healthcare innovation.
In Newsweek’s latest ranking of the world’s best hospitals, Sahlgrenska University Hospital is ranked 66th globally, improving from 69th place the previous year. The ranking reflects the hospital’s ongoing commitment to delivering high-quality, patient-centred care while advancing research, education and innovation.
“Our ambition is to become one of Europe’s leading university hospitals by 2032. This year’s ranking suggests that our continued focus on patients, staff and the development of healthcare services is being recognised internationally,” says Boubou Hallberg, Chief Executive Officer of Sahlgrenska University Hospital.
“During the past year, we have expanded our international collaborations while increasing our capacity. We have significantly reduced the number of patients waiting more than one year for surgery, and bed occupancy rates have decreased, creating better conditions for both patients and staff.”
Over the past four years, Sahlgrenska University Hospital has steadily advanced in Newsweek’s global rankings, moving from 45th to 36th place among European hospitals and from 84th to 66th place worldwide, among more than 2,500 hospitals evaluated.
Newsweek’s assessment combines several measures, including peer recommendations from thousands of healthcare professionals, quality indicators and patient-reported outcome measures (PROMs). PROMs capture patients’ own experiences of their health and quality of life following treatment or other healthcare interventions through standardised questionnaires.
“We are particularly proud of the recognition of our work with patient-reported outcomes,” says Boubou Hallberg. “Only a small number of the world’s highest-ranked hospitals receive the top rating in this category, and Sahlgrenska University Hospital is one of them.”
Advancing Care Through International Collaboration
International collaboration continues to play an important role in the hospital’s development. During 2025, Sahlgrenska University Hospital strengthened partnerships across the life sciences sector, including strategic collaborations with healthcare organisations, academic institutions and industry partners.
These include partnerships with the National University Health System (NUHS) in Singapore, Oslo University Hospital and leading life science companies such as AstraZeneca. Through these collaborations, the hospital contributes to the development of new treatments, healthcare innovation and the translation of research into clinical practice.
International Interest in Specialised Care
Several of the hospital’s highly specialised services are also attracting growing international attention.
One example is isolated limb perfusion (ILP), an advanced treatment used for selected tumours affecting the arms or legs. Sahlgrenska University Hospital is the only centre in Sweden providing this treatment and is internationally recognised for its expertise in both clinical care and research within the field.
In 2025, specialists from Memorial Sloan Kettering Cancer Center in New York, one of the world’s leading cancer centres, visited Gothenburg to learn more about the hospital’s experience with the technique and its clinical outcomes.
The visit reflects the increasing international interest in the highly specialised care provided at Sahlgrenska University Hospital and the hospital’s contribution to the advancement of healthcare through clinical excellence, research and international knowledge exchange.